Core Laboratory Infectious Disease

Infectious Disease — Syphilis

Contact a Rep HTML

Request more information about Roche's Syphilis Assay.

Please complete the form below to speak with a Roche representative.

 
 
 
 
Overview

Elecsys® Syphilis assay

Research has proven treponemal testing is more effective in identifying disease in the early and late-latent stages.1

Help stop a growing problem with early and accurate detection.

100% sensitivity in untreated syphilis across all stages of the disease

No prozone effect reduces the risk of false negatives

Shortest time to results — 18 minutes

Small 10 μL sample volume offers greater convenience

Syphilis is staging a comeback

To learn more about our portfolio,
Visit our syphilis resources page.

Infectious Disease Portfolio

References:

  1. Binnicker, M.J. (2012). “Which algorithm should be used to screen for syphilis?” Current Opinion in Infectious Diseases 25:79–85.
  2. Sexually Transmitted Disease Surveillance 2015. Centers for Disease Control and Prevention. Atlanta: U.S. Department of Health and Human Services; 2016. https://www.cdc.gov/std/stats15/default.htm (accessed July 7, 2017).
  3. Syphilis. Centers for Disease Control and Prevention. http://www.cdc.gov/std/stats14/syphilis.htm#foot4(accessed October 3, 2017.)
  4. Changing the story of syphilis. Centers for Disease Control and Prevention. http://www.cdc.gov/std/products/success/changing-the-story-of-syphilis-success-story-508c.pdf(accessed September 26, 2016)
  5. HIV prevention through early detection and treatment of other sexually transmitted diseases—United States. Recommendations of the Advisory Committee for HIV and STD prevention. MMWR Recommendations and Reports. 1998;47(RR-12):1–24.
Resources

Outside of Pepper mode, this text will be replaced by the resource cards.

Contact Us

Outside of Pepper mode, this text will be replaced by the content added in the above "Contact a Rep HTML" code editor.